Aspirin Dose and Prevention of Coronary Abnormalities in Kawasaki Disease
Frédéric Dallaire(Université Laval), Rosie Scuccimarri(Montreal Children's Hospital), Anita Dhanrajani(Center for Rheumatology), Audrey Dionne(Centre Hospitalier Universitaire Sainte-Justine), Dania Basodan(Montreal Children's Hospital), Harrison Saulnier(Montreal Children's Hospital), Soha Rached-d’Astous(Centre Hospitalier Universitaire Sainte-Justine), Brian W. McCrindle(University of Toronto), Samuel Blais(Université de Sherbrooke), Astrid M. De Souza(University of British Columbia), Kimberley Kaspy(Montreal Children's Hospital), Derek G. Human(University of British Columbia), Zoe Fortier-Morissette(Université de Sherbrooke), Joël Blanchard(Université de Sherbrooke), Nagib Dahdah(HTC (Taiwan)), Mathew Mathew(University of Toronto), Claudia Renaud
Cited by 89
Related Papers
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
|Circulation|2017|3.7k
The Agenda for Familial Hypercholesterolemia
|Circulation|2015|726
Noninvasive Assessment of Subclinical Atherosclerosis in Children and Adolescents
|Hypertension|2009|633
Reduced Fetal Cerebral Oxygen Consumption Is Associated With Smaller Brain Size in Fetuses With Congenital Heart Disease
|Circulation|2015|530
Contemporary Outcomes After the Fontan Procedure
|Journal of the American College of Cardiology|2008|441